Fig. 1From: Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcomaSarcoma specific 5 year-survival of 46 patients with RSTS who underwent surgical resection divided by R-status (R0-margin [yellow] 77.6% vs. R1-margin [blue] 70.0% vs. R2-margin [red] 42.9%; p = 0.03)Back to article page